Skip to main content

Table 2 Univariate and multivariate analyses of factors associated with overall survival and cumulative recurrence

From: Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma

Factors

overall survival

cumulative recurrence

 

Univariate

 

Mulvariate

 

Univariate

 

Mulvariate

 

P value

HR

95%Cl

P value

P value

HR

95% Cl

P value

Gender (Female vs. Male)

0.060

  

NA

0.127

  

NA

Age (years) (≥53 vs. < 53)

0.888

  

NA

0.469

  

NA

Liver cirrhosis (yes vs. no)

0.930

  

NA

0.127

  

NA

HBsAg (positive vs. negative)

0.183

  

NA

0.622

  

NA

HCV (positive vs. negative)

0.983

  

NA

0.793

  

NA

Serum AFP, ng/mL (≥20 vs. < 20)

0.065

  

NA

0.011

  

NS

Tumor differentiation (III/IV vs. I/II)

0.197

  

NA

0.069

  

NA

Edmondson-Steiner Grade (I/II vs. III)

0.191

  

NA

0.018

  

NS

Tumor encapsulation (yes vs. no)

0.195

  

NA

0.043

  

NS

TNM stage (I/II vs. III/IV)

0.005

  

NS

0.086

  

NA

Tumor size (diameter, cm) (≥5 vs. < 5)

0.001

1.587

1.043–2.414

0.031

0.001

1.823

1.247–2.665

0.002

Embolus (Absence vs. Present)

< 0.001

2.232

1.472–3.385

< 0.001

< 0.001

  

NS

Tumor number (multiple vs. single)

0.045

  

NS

0.002

2.121

1.366–3.294

0.001

RNF38 staining (high vs. low)

< 0.001

2.046

1.321–3.171

0.001

0.001

1.642

1.117–2.415

0.012

  1. Abbreviations: 95% CI 95% confidence interval, AFP alpha-fetoprotein, TNM tumor node metastasis, HBsAg hepatitis B surface antigen, HCV hepatitis C virus, HR hazard ratio, NA not adopted, NS not significant
  2. Cox proportional hazards regression model